1 min read
Boston Scientific Prices $3 Billion in U.S. Notes and €4.25 Billion in Euro Notes
Boston Scientific priced the U.S. notes across four tranches due from 2029 to 2036. An indirect wholly owned subsidiary priced the euro notes.

Boston Scientific priced $3 billion in U.S. dollar-denominated senior notes across four tranches, while an indirect wholly owned finance subsidiary priced a separate €4.25 billion euro note offering.
The U.S. notes have maturities ranging from 2029 to 2036. The euro-denominated notes were priced by American Medical Systems Europe B.V., the company's indirect wholly owned finance subsidiary.